Critically-ill pediatric patients with COVID-19. An update

Area of Science:

• Pediatric critical care medicine
• Infectious diseases
• Epidemiology

Background:

• The COVID-19 pandemic has necessitated rapid evidence generation for treatment optimization.
• Pediatric COVID-19 generally presents with lower severity than adult cases.
• Severe disease disproportionately affects infants and children with comorbidities.

Purpose of the Study:

• To review and synthesize current literature on the clinical presentation of severe COVID-19 in critically ill children.
• To summarize existing evidence regarding the management strategies for critically ill pediatric patients with COVID-19.

Main Methods:

• Systematic review of published literature.
• Analysis of clinical course and treatment data from pediatric COVID-19 cases.
• Synthesis of findings to inform evidence-based recommendations.

Main Results:

• Limited data exists on severe pediatric COVID-19 due to low incidence.
• Key risk factors for severe disease include young age (infants) and pre-existing medical conditions.
• Management strategies are evolving, often extrapolated from adult data.

Conclusions:

• Further research is needed to establish evidence-based guidelines for pediatric COVID-19 critical care.
• Understanding the specific clinical trajectory in children is crucial for effective resource allocation and treatment.
• Collaboration and data sharing are essential to address knowledge gaps in pediatric infectious disease management.